This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugawara, A. Articles by Abe, K. Search for Related Content PubMed PubMed Citation Articles by Sugawara, A. Articles by Abe, K.

Retinoid X Receptors in the Kidney: Their Protein Expression and Functional Significance

The 2nd Department of Internal Medicine (A.S., N.T., K.A.), Tohoku University School of Medicine, Sendai 980 Japan; and Department of Pathology (N.S., R.Y.O.), Tokai University School of Medicine, Isehara-city 259-11, Japan

Address all correspondence and requests for reprints to: Dr. Akira Sugawara, The 2nd Department of Internal Medicine, Tohoku University School of Medicine, 1-1 Seiryo-cho, Aoba-ku, Sendai 980, Japan.

Retinoid X receptors (RXRs) heterodimerize with 1,25-dihydroxyvitamin D₃ (VD) receptor (VDR), and play important roles in VD-regulated transactivation. VD acts on many tissues including kidney for the regulation of calcium homeostasis. In the kidney, the expression of VDR in the tubular cells has been well studied. In contrast, little is known about the localization and the functional significance of RXRs there. In order to elucidate these questions, we first performed immunohistochemical analyses of rat kidney using isoform-specific antimouse RXR antibodies we have previously reported. Interestingly, all RXR isoforms, predominantly RXR, mainly localized to the proximal and the distal tubules, but not to the glomeruli. The serial section staining using anti-VDR antibody showed the colocalization of RXR and VDR in those tubular cells. In order to elucidate the functional significance of endogenous receptors in the tubular cells, we next performed transient transfection studies using the tubular-cell derived Madin-Darby bovine kidney cells, which express both endogenous VDR and RXR. We transfected a reporter plasmid containing direct repeat 3 (DR3) sequence, to which only RXR/VDR heterodimer can bind, and found that VD and 9-cis retinoic acid, as well as VD and RXR selective agonist LG100153, had an additive effect for the DR3 transactivation. Taken together, we speculate that endogenous RXRs co-localize with VDR, and coregulate VD-dependent genes in the tubular cells of the kidney as RXR/VDR heterodimer.

This article has been cited by other articles:

				J. Adams, E. Kiss, A. B.V. Arroyo, M. Bonrouhi, Q. Sun, Z. Li, N. Gretz, A. Schnitger, C. C. Zouboulis, M. Wiesel, et al. 13-cis Retinoic Acid Inhibits Development and Progression of Chronic Allograft Nephropathy Am. J. Pathol., July 1, 2005; 167(1): 285 - 298. [Abstract] [Full Text] [PDF]

				S. Liebler, B. Uberschar, H. Kubert, S. Brems, A. Schnitger, M. Tsukada, C. C. Zouboulis, E. Ritz, and J. Wagner The renal retinoid system: time-dependent activation in experimental glomerulonephritis Am J Physiol Renal Physiol, March 1, 2004; 286(3): F458 - F465. [Abstract] [Full Text]

				A. Sugawara, K. Takeuchi, A. Uruno, Y. Ikeda, S. Arima, M. Kudo, K. Sato, Y. Taniyama, and S. Ito Transcriptional Suppression of Type 1 Angiotensin II Receptor Gene Expression by Peroxisome Proliferator-Activated Receptor-{{gamma}} in Vascular Smooth Muscle Cells Endocrinology, July 1, 2001; 142(7): 3125 - 3134. [Abstract] [Full Text] [PDF]

				V. Haxsen, S. Adam-Stitah, E. Ritz, and J. Wagner Retinoids Inhibit the Actions of Angiotensin II on Vascular Smooth Muscle Cells Circ. Res., March 30, 2001; 88(6): 637 - 644. [Abstract] [Full Text] [PDF]

				J. Wagner Potential role of retinoids in the therapy of renal disease Nephrol. Dial. Transplant., March 1, 2001; 16(3): 441 - 444. [Full Text] [PDF]

				D. Li, V. Desai-Yajnik, E. Lo, M. Schapira, R. Abagyan, and H. H. Samuels NRIF3 Is a Novel Coactivator Mediating Functional Specificity of Nuclear Hormone Receptors Mol. Cell. Biol., October 1, 1999; 19(10): 7191 - 7202. [Abstract] [Full Text] [PDF]

				M. Imaizumi, H. Suzuki, M. Yoshinari, A. Sato, T. Saito, A. Sugawara, S. Tsuchiya, Y. Hatae, T. Fujimoto, A. Kakizuka, et al. Mutations in the E-Domain of RARalpha Portion of the PML/RARalpha Chimeric Gene May Confer Clinical Resistance to All-trans Retinoic Acid in Acute Promyelocytic Leukemia Blood, July 15, 1998; 92(2): 374 - 382. [Abstract] [Full Text] [PDF]

				K. Prufer, A. Racz, G. C. Lin, and J. Barsony Dimerization with Retinoid X Receptors Promotes Nuclear Localization and Subnuclear Targeting of Vitamin D Receptors J. Biol. Chem., December 22, 2000; 275(52): 41114 - 41123. [Abstract] [Full Text] [PDF]

				I. Lehrke, M. Schaier, K. Schade, C. Morath, R. Waldherr, E. Ritz, and J. Wagner Retinoid receptor-specific agonists alleviate experimental glomerulonephritis Am J Physiol Renal Physiol, April 1, 2002; 282(4): F741 - F751. [Abstract] [Full Text] [PDF]